4
Changes in Ownership
Aldeyra Therapeutics, Inc. Filed Acc 0000899243-19-023128
Chief Commerical Officer bought 4,329 shares at $4.68 ($20,260)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McMullin David Chief Commerical Officer | 2019-09-05 | Purchase | +4,329 | $4.68 | $20,260 | 6,148 | D |
| Open-market purchases · 4,329 sh · avg $4.68 · $20,260 | |||||||
Loading xslF345X03/doc4.xml…